Abstract
A new immunoadsorbent (I-02), which consists of modified polyvinyle alchole gel, has been developed and I-02 hemoperfusion system has been devised. The I-02 hemoperfusion was carried out to evaluate the biocompatibility of the system. No remarkable changes in biochemical and coagolation parameters were noted. The experimental dogs tolerated the procedure well. The procedure has been easily and safely performed.